SEC 13F Intelligence

Westchester Capital Management, LLC / AMED

Westchester Capital Management, LLC’s Amedisys Inc Position

Does Westchester Capital Management, LLC own Amedisys Inc (AMED)? Not currently — the last reported position was 154.6K shares worth $15M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$15M
Q2 2025
Shares
154.6K
% of Portfolio
+0.80%
Quarters Held
9
position exited

Position History AMED

Reported value by quarter
Q2 ’23: $21MQ2 ’23Q3 ’23: $79MQ4 ’23: $84MQ4 ’23Q1 ’24: $90MQ2 ’24: $94MQ2 ’24Q3 ’24: $108MQ4 ’24: $17MQ4 ’24Q1 ’25: $13MQ2 ’25: $15MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025154.6K$15M+0.80%
Q1 2025138.7K$13M+0.66%
Q4 2024189.8K$17M+0.94%
Q3 20241.12M$108M+4.61%
Q2 20241.02M$94M+3.52%
Q1 2024981.1K$90M+3.32%
Q4 2023879.4K$84M+2.93%
Q3 2023850.4K$79M+2.32%
Q2 2023230.0K$21M+0.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Westchester Capital Management, LLC’s full portfolio or all institutional holders of AMED.